This article is a Preprint
Preprints are preliminary research reports that have not been certified by peer review. They should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Preprints posted online allow authors to receive rapid feedback and the entire scientific community can appraise the work for themselves and respond appropriately. Those comments are posted alongside the preprints for anyone to read them and serve as a post publication assessment.
How to overcome the stagnation of the first dose vaccine coverage curve against covid-19 in Brazil? / Como superar a estagnação da curva de cobertura vacinal de primeira dose contra covid-19 no Brasil?
Preprint
in Portuguese
| SciELO Preprints
| ID: pps-3380
Responsible library:
BR1.1
ABSTRACT
This study described the temporal evolution of first-dose vaccination coverage against Covid-19 in Brazil and in the states. The country has 84.86% of the population eligible for vaccination and currently coverage for the first dose is 74.95%. There has been a slowdown in the application of first doses in Brazil since epidemiological week 36 (APC 0.83%, 95% CI 0.75 - 0.91%), with a trend close to stagnation, synchronized with the beginning of the debate on the effectiveness of vaccine and proximity to the population limit eligible for vaccination. It is important to create strategies to increase the population's access to vaccination posts. Furthermore, it is urgent to seek approval for vaccination in children, increasing the eligible population.
RESUMO
Este estudo descreveu a evolução temporal da cobertura vacinal de primeira dose contra a Covid-19 no Brasil e estados. O país possui 84,86% da população elegível para vacinação e atualmente a cobertura de primeira dose é de 74,95%. Há uma desaceleração na aplicação de primeiras doses no Brasil desde a semana epidemiológica 36 (APC 0,83%, IC 95% 0,75 0,91%), com tendência próxima de estagnação, sincronizadas com o início do debate sobre efetividade da vacina e proximidade do limite de população elegível à vacinação. É importante criar estratégias para aumentar o acesso da população aos postos de vacinação. Além disso, é urgente buscar a aprovação da vacinação em crianças, aumentando a população elegível.
Full text:
Available
Collection:
Preprints
Health context:
Sustainable Health Agenda for the Americas
Health problem:
Goal 5: Medicines, vaccines and health technologies
Database:
SciELO Preprints
Country/Region as subject:
South America
/
Brazil
Language:
Portuguese
Year:
2021
Document type:
Preprint
